Related Experiment Video
Updated: Jan 26, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Understanding the immunology of the Zostavax shingles vaccine
Nicole L Sullivan1, Christiane S Eberhardt2, Andreas Wieland3
1MRL, Department of Infectious Diseases and Vaccines, Merck & Co., Inc., Kenilworth, New Jersey, USA.
Abstract:
Zostavax is a live-attenuated varicella zoster virus (VZV) vaccine recommended for use in adults >50 years of age to prevent shingles. The main risk factor for the development of shingles is age, which correlates with decreasing cell-mediated immunity. These data suggest a predominant role of T cell immunity in controlling VZV latency. However, other components of the immune system may also contribute. In this review, we will discuss how the immune system responds to Zostavax, focusing on recent studies examining innate immunity, transcriptomics, metabolomics, cellular, and humoral immunity.
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Understanding the Self
Understanding Memory
Understanding Love
Understanding Consciousness
Sleep, a crucial state, is characterized by reduced...

